Protocol - Growth Charts

Description

The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) growth charts include both standard graph lines and a series of percentile curves that demonstrate the distribution of certain body measurements in individuals. Each growth chart may illustrate a specific gender and age range. The percentile curves on each chart depend on which measurement is being recorded.

The percentile curves on the WHO and CDC growth charts are for individuals who appear to be unaffected by a condition impacting growth. To provide information for special populations, growth charts for specific conditions have been developed; these growth charts contain percentile curves for the distribution of body measurements in individuals with the specific condition. Some conditions with a specific growth chart are cerebral palsy, achondroplasia, Turner syndrome, and Duchenne muscular dystrophy (DMD).

Specific Instructions

The Rare Genetic Conditions Working Group (WG) acknowledges that the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) growth charts provide important information for growth comparisons between an individual with a rare genetic condition and others without such a condition. However, when available, the growth of an individual with a rare genetic condition should also be recorded and tracked on growth charts that are specific for their condition.

The protocol for how to measure head circumference is not provided in this protocol. The PhenX protocol for head circumference is widely used.

Note: For achondroplasia and Turner syndrome, the WG recommends the CDC growth charts be used to assess weight for age, weight for height, and BMI for age.

The WHO and CDC growth charts and a detailed online training course are available on the CDC website at www.cdc.gov/growthcharts/who_charts.htm, www.cdc.gov/growthcharts/cdc_charts.htm and www.cdc.gov/nccdphp/dnpao/growthcharts/who/index.htm, respectively.

Once the appropriate growth charts are obtained, follow the CDC recommendation, background, purpose and six steps (see below) regarding their use and interpretation. (Note this information is also available in a PDF from the CDC website at:

www.cdc.gov/nccdphp/dnpa/growthcharts/resources/growthchart.pdf.)

CDC Recommendation

• Use the WHO growth charts for all children from birth up to 2 years of age to monitor growth in the United States. The WHO growth standards for children younger than 2 years have been adapted for use in the United States.

• Use the CDC growth charts for children and teens aged 2 through 19 years to monitor growth in the United States.

Background

• The WHO growth charts are international standards that show how healthy children should grow. The standards describe the growth of children living in six countries (including the United States) in environments believed to support optimal growth. One of the several criteria defined for optimal growth is breastfeeding. The WHO growth charts use the growth of breastfed infants as the norm for growth. This is in agreement with national guidelines that recommend breastfeeding as the optimal infant feeding method. The WHO growth charts should be used with all children up to aged 2 years, regardless of type of feeding.

• The CDC growth charts are a national reference that represent how US children and teens grew primarily during the 1970s, 1980s and 1990s. The CDC recommends using the references from ages 2 through 19 years so health care providers can track weight, stature, and body mass index (BMI) from childhood through age 19 years.

Purpose

• This guide instructs health care providers on how to use and interpret the WHO and CDC growth charts to assess physical growth among children and teens. Comparing body measurements with the appropriate age- and sex-specific growth chart enables health care providers to monitor growth and identify potential health- or nutrition-related problems.

During routine screening, health care providers assess physical growth using the head circumference, weight and length of infants and children up to 2 years of age and the weight, stature (also referred to as height), and BMI of children and teens from aged 2 through 19 years. Although one measurement plotted on a growth chart can be used to screen children for nutritional risk, it does not provide adequate information to determine the child’s growth pattern. When plotted correctly, a series of accurate measurements offer important information about a child’s growth pattern. Gestational age, birth weight, and parental stature should be considered since they may influence a child’s growth pattern. Parental stature, for example, should be considered before assuming there is a health or nutrition concern. Other factors, such as the presence of a chronic illness or special health care need, must be considered, and further evaluation may be necessary.

Availability

Available

Download PDF

Protocol

S T E P

1 Obtain accurate measurements When weighing and measuring children, follow procedures that yield accurate measurements and use equipment that is well maintained. For weight and height measurements, refer to the PhenX Height and Weight Measures. (Note: for consistency, this sentence has been modified to reference PhenX measures, instead of the reference in the original protocol)

2 Select the appropriate growth chart Select the growth chart to use based on the age and sex of the child being weighed and measured.

Enter the child’s name and the record number, if appropriate.

Use the charts listed below when measuring weight and length of children from birth up to 2 years of age:		Use the charts listed below when measuring weight and stature in children and teens aged 2 through 19 years:
• WHO Weight-for-age		• CDC Weight-for-age
• WHO Length-for-age		• CDC Stature-for-age
• WHO Weight-for-length		• CDC BMI-for-age

3 Record data After selecting the appropriate chart and entering the patient’s name and record number, if appropriate, complete the data entry table.

First, record information about factors obtained at the initial visit that influence growth.

• Enter mother’s and father’s stature as reported.

• Enter the gestational age in weeks. (Omit this step when using the CDC growth charts for children and teens aged 2 to 20 years.)

The next line is reserved for recording the child’s birth data. (Omit this step when using the CDC growth charts for children and teens aged 2 to 20 years.)

• Enter the date of birth.

• Enter birth weight and length.

• Add notable comments (e.g., breastfeeding).

Record information obtained during the current visit.

• Enter today’s date.

Determine age to the nearest month for infants and children up to 2 years and to the nearest 1/4-year for children aged 2 to 20 years.

• Enter the child’s age.

• Enter weight, and length or stature, immediately after taking the measurement.

• Add any notable comments (e.g., was not cooperative).

Example of how to calculate the child’s age: To calculate Sam’s age, subtract his birth date from the date of the visit or measurement. To subtract, it will be necessary to convert months to days and years to months if either the month or day in the birth data is larger than in the date of measurements. When converting one month to days, subtract 1 from the number of months in the date of measurement, then add 28, 30, or 31, as appropriate, to the number of days. When converting one year to months, subtract 1 from the number of years in the date of measurement, then add 12 to the number of months.

Days à Months		Months à Year
0-15	0	0-1	40
16-31	1	2-4	1/4
Using the guide above, 3 years, 6 months, and 19 days is rounded to 3 years and 7 months. Because age for children over 2 is rounded to the nearest ¼ year, Sam’s age is rounded to 3 ½ years		5-7	1/2
		8-10	3/4
		11-12	1

	Year	Month	Day
Date of Measurement	1998	4	4
Convert one month to days	1998	(-1) 3	(+30) 34
Convert one year to months	(-1) 1997	(+12) 15	34
Birth Date	1994	9	15
Child’s Age	3	6	19

Sam is aged 3 years, 6 months, and 19 days.

4 Calculate BMI when a child is aged 2 to 20 years BMI is calculated using weight and stature measurements, then used to compare a child’s weight relative to stature with other children of the same age and sex in the reference population.

• Using a calculator, hand-held device or software, determine BMI using the calculation below. The Rare Genetic Conditions WG slightly revised the below calculation and added the example.

BMI = [Weight (kg) ÷ (Stature (cm) x Stature (cm))] x 10,000

BMI = [Weight (lb) ÷ (Stature (in) x Stature (in))] x 703

For example: If an individual’s weight is 70kg and their stature is 180cm, then their BMI would be calculated as follows:

BMI = [Weight (kg) ÷ (Stature (cm) x Stature (cm))] x 10,000

BMI = [ 70 kg ÷ (180 cm x 180 cm)] x 10,000 = [70 ÷ 32,400] x 10,000 = 0.002160 x 10,000 = 21.60

It is necessary to convert the weight and stature measurements to the appropriate decimal value shown in Table 1.

Example: 37 lbs. 4 oz. = 37.25 lbs., 41-1/2 inches = 41.5 in.

Table 1. Decimal Conversions

Fraction	Ounces	Decimal
1/8	2	.125
1/4	4	.25
3/8	6	.375
1/2	8	.5
5/8	10	.625
3/4	12	.75
7/8	14	.875

• Enter BMI to one place after the decimal point (Example: 15.204 = 15.2).

For more information and additional resources on calculating BMI, see Using the CDC BMI-for-age Growth Charts for Children and Teens Aged 2 to 20 Years at www.cdc.gov/nccdphp/dnpa/growthcharts/training/modules/module1/text/page1a.htm

5 Plot measurements On the appropriate WHO or CDC growth chart, plot the measurements recorded in the data entry table for the current visit.

• Find the child’s age on the horizontal axis. When plotting weight-for-length, find the length on the horizontal axis. Use a straight edge or right-angle ruler to draw a vertical line up from that point.

• Find the appropriate measurement (weight, length, stature, or BMI) on the vertical axis. Use a straight edge or right-angle ruler to draw a horizontal line across from that point until it intersects the vertical line.

• Make a small dot where the two lines intersect.

6 Interpret the plotted measurements The curved lines on the growth chart show selected percentiles that indicate the rank of the child’s measurement. For example, when the dot is plotted on the 95th percentile line on the CDC BMI-for-age growth chart, it means that 5 of 100 children (5%) of the same age and sex in the reference population have a higher BMI-for-age.

The WHO growth standard charts use the 2nd and the 98th percentiles as the outer most percentile cutoff values indicating abnormal growth.

The CDC growth reference charts use the 5th and the 95th percentiles as the outermost percentile cutoff values indicating abnormal growth.

Interpret the plotted measurements based on the percentile ranking on the WHO or the CDC growth charts and the percentile cutoff value corresponding to the nutrition indicator shown in the table below. If the percentile rank indicates a nutrition-related health concern, additional monitoring and assessment are recommended.

• Determine the percentile rank.

• Determine if the percentile rank suggests that the anthropometric index is indicative of nutritional risk based on the percentile cutoff value.

• Compare today’s percentile rank with the rank from previous visits to identify any major shifts in the child’s growth pattern and the need for further assessment.

When transitioning from the WHO growth charts to the CDC growth charts at aged 2 years, a change in growth classification may occur. During this transition, caution should be used in interpreting any changes in classification.

Anthropometric Index	Percentile Cut-off Values	Nutritional Status Indicato
WHO Growth Charts 2nd and 98th percentiles
Length-for age	< 2^nd	Short stature
Weight-for-length	< 2^nd	Low weight-for-length
Weight-for-length	> 98^th	High weight-for-length
CDC Growth Charts 5th and 95th percentiles
BMI-for-age	> 95^th	Obesity
BMI-for-age	> 85^th and < 95^th	Overweight
BMI-for-age	< 5^th	Underweight
Stature-for-age	< 5^th	Short stature

Cerebral palsy:

Growth charts are available for indivduals with cerebral palsy at the Life Expectancy Project’s website: www.lifeexpectancy.org/articles/NewGrowthCharts.shtml This site contains weight-for-age, height-for-age, and BMI-for-age growth charts, for individuals age 2 to 20 years old. The charts are strafied by gender and the Gross Motor Function Classification System (GMFCS). Additionally, there are separate charts for individuals with a level 5 GMFCS who require a feeding tube and those who do not require a feeding tube.

Note: the proper use of growth charts require an accurate height and weight of the individual. The Rare Genetic Conditions Working Group recommends investigators use the height and weight measures in the PhenX Toolkit, if they do not have an individual’s height/weight.

Achondroplasia:

Growth charts are available for individuals with achondroplasia at the Little People of America’s (LPA) Medical Resource Center website. The charts are separated by gender and the age range is 0-18 years (depending upon the feature which is being plotted). There are charts to plot height for age, head circumference, segmental growth, and other measurements. See the "Specific Instructions" section for the Rare Genetic Conditions Working Group’s suggestions regarding other measurements.

The growth charts listed below are specific to individuals with achondroplasia. These charts are available via the links below and also on the LPA Medical Resource Center website.

Turner Syndrome:

A growth chart for height for age is available from the Abbott Nutrition Health Institute:

images.abbottnutrition.com/ANHI2010/MEDIA/BC%20Decker%20Appendix%20Fig%2047-50%20Turner%20Syndrome.pdf

This chart is for girls with Turner syndrome who are 2-19 years old and have not been receiving hormone therapy.

Duchenne Muscular Dystrophy:

Dr. Nancy West and colleagues have developed growth charts for males with Duchenne muscular dystrophy (DMD). These charts are for weight for age, height for age, and BMI for age and apply to males with DMD who are age 2-12 years, ambulatory, and steroid-naïve. These charts are available in the publication titled: "Patterns of Growth in Ambulatory Males with Duchenne Muscular Dystrophy." Publication details are listed in the "Source" section.

Personnel and Training Required

Technicians should be trained in the basic techniques of anthropometric measurements.

Equipment Needs

Stadiometer with a fixed-length backboard and an adjustable headpiece, digital scale, or beam balances.

Requirements

Requirement Category	Required
Major equipment	No
Specialized training	No
Specialized requirements for biospecimen collection	No
Average time of greater than 15 minutes in an unaffected individual	No

Mode of Administration

Physical Examination

Lifestage

Infant, Toddler, Child, Adolescent, Adult

Participants

Individuals from birth to 20 years old.

Selection Rationale

The Centers for Disease Control and Prevention (CDC) recommends the use of the World Health Organization (WHO) growth charts to monitor growth in individuals from birth to 2 years old and the use of its growth charts for individuals age 2-20 years. Additionally, per the CDC website (www.cdc.gov/growthcharts/), growth charts contribute to forming an overall clinical impression and are not intended to be used as a sole diagnostic tool. The Rare Genetic Conditions Working Group agrees with this recommendation and use of growth charts.

Language

English

Standards

Standard	Name	ID	Source
Human Phenotype Ontology	Growth delay	HP:0001510	HPO
Human Phenotype Ontology	Growth abnormality	HP:0001507	HPO
caDSR Form	PhenX PX221201 - Growth Charts	6202744	caDSR Form

Derived Variables

None

Process and Review

This section will be completed when reviewed by an Expert Review Panel.

Protocol Name from Source

World Health Organization (WHO) & Centers for Disease Control and Prevention (CDC) growth charts

Source

Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO): www.cdc.gov/growthcharts/ and www.cdc.gov/nccdphp/dnpa/growthcharts/resources/growthchart.pdf

Cerebral Palsy:

The Life Expectancy Project website: www.lifeexpectancy.org/articles/NewGrowthCharts.shtml

Achondroplasia:

Little People of America Medical Resource Center: lpamrs.memberclicks.net/index.php?option=com_content&view=article&id=66

Hecht, J. T., Horton, W. A., Reid, C. S., Pyeritz, R. E., & Chakraborty, R. (1989). Growth of the foramen magnum in achondroplasia. American Journal of Medical Genetics, 32, 528-535.

Horton, W. A., Rotter, J. I., Rimoin, D. L., Scott, C. I., & Hall, J. G. (1978). Standard growth curves for achondroplasia. Journal of Pediatrics, 93, 435-438.

Turner Syndrome:

Lyon, A. J., Preece, M. A., & Grant, D. B. (1985). Growth curve for girls with Turner syndrome. Archives of Disease in Childhood, 60, 932-935.

AbbottNutritionHealthInstitute.org With permission from Duggan C, et al. (2008). Nutrition in pediatrics (4^th ed.). Hamilton, Ontario, Canada: BC Decker Inc.

Duchenne Muscular Dystrophy:

West, N. A., Yang, M. L., Weitzenkamp, D. A., Andrews, J., Meaney, F. J., Oleszek, J., Miller, L. A., Matthews, D., & DiGuiseppi, C. (2013). Patterns of growth in ambulatory males with Duchenne muscular dystrophy. Journal of Pediatrics, 163, 1759-1763.

General References

American Academy of Pediatrics. (2009). Pediatric nutrition handbook (6th ed.). Elk Grove Village, IL: American Academy of Pediatrics.

Barlow, S. E.; Expert Committee. (2007). Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics, 120(Suppl. 4), S164-S192.

Brooks, J., Day, S.M., Shavelle, R.M., & Strauss, D.J. (2011). Low weight, morbidity, and mortality in children with cerebral palsy: New clinical growth charts. Pediatrics, 128; e299; originally published online July 18, 2011 (DOI 10.1542/peds.2010-2801).

Dewey, K. G., Cohen, R. J., Nommsen-Rivers, L. A., & Heinig, M. J.; WHO Multicenter Growth Reference Study Group. (2004). Implementation for the WHO Multicentre Growth Reference Study in the United States. Food and Nutrition Bulletin, 25(Suppl. 1), S84-S89.

Grummer-Strawn, L. M., Reinold, C., & Krebs, N. F.; Centers for Disease Control and Prevention. (2010). Use of the World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recommendations and Reports, 59(RR-9), 1-15.

Kuczmarski, R. J., Ogden, C., Grummer-Strawn, L., Flegal, K. M., Guo, S. S., Wei, R., Johnson, C. L. (2000). CDC growth charts: United States. Advance Data, 314, 1-27.

Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer-Strawn, L., Flegal, K. M., Mei, Z., Johnson, C. L. (2002). 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat 11(246), 1-190.

World Health Organization. (1995). Physical status: The use and interpretation of anthropometry (WHO Technical Report Series 854). Geneva, Switzerland: Author.

World Health Organization. (2006). WHO child growth standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva, Switzerland: Author.

Protocol ID

221201

Variables

Export Variables

Variable Name	Variable ID	Variable Description	dbGaP Mapping
PX221201_Growth_Chart_Birth_Length
	PX221201080000	Child's Birth length	Variable Mapping
PX221201_Growth_Chart_Birth_Weight
	PX221201070000	Child's Birth Weight	N/A
PX221201_Growth_Chart_Child's_Age
	PX221201110000	Child's age today	Variable Mapping
PX221201_Growth_Chart_Current_BMI
	PX221201150000	BMI = [Weight (kg) ÃƒÂ· (Stature (c more ) x Stature (cm))] x 10,000 show less	Variable Mapping
PX221201_Growth_Chart_Current_LengthStature
	PX221201130000	Child's length/stature today	N/A
PX221201_Growth_Chart_Current_Notable_Comments
	PX221201140000	Notable comments on current growth	N/A
PX221201_Growth_Chart_Current_Weight
	PX221201120000	Child's weight today	Variable Mapping
PX221201_Growth_Chart_Date_Of_Birth
	PX221201060000	Child's Date of Birth	Variable Mapping
PX221201_Growth_Chart_Fathers_Stature
	PX221201040000	Father of Patient - Stature	N/A
PX221201_Growth_Chart_Gestational_Age
	PX221201050000	Child's Gestational Age	Variable Mapping
PX221201_Growth_Chart_High_WeightForLength
	PX221201180000	High Weight Table	N/A
PX221201_Growth_Chart_Low_WeightForLength
	PX221201170000	Low Weight Table	N/A
PX221201_Growth_Chart_Mothers_Stature
	PX221201030000	Mother of Patient - Stature	N/A
PX221201_Growth_Chart_Notable_Comments
	PX221201090000	Notable comments on birth	N/A
PX221201_Growth_Chart_Obesity
	PX221201190000	BMI for Age Obeese	Variable Mapping
PX221201_Growth_Chart_Overweight
	PX221201200000	BMI for Age Overweight	Variable Mapping
PX221201_Growth_Chart_Patient_Name
	PX221201010000	Patient Name	N/A
PX221201_Growth_Chart_Patient_Record_Number
	PX221201020000	Patient Record Number	N/A
PX221201_Growth_Chart_Short_Stature
	PX221201160000	Short Stature table	N/A
PX221201_Growth_Chart_Today's_Date
	PX221201100000	Today's date	Variable Mapping

Rare Genetic Conditions

Measure Name

Growth Charts

Release Date

April 30, 2015

Definition

A standardized method to record and track the growth of an individual. This method can be used to track growth by length (i.e., height), weight, body mass index (BMI), and head circumference.

Purpose

Information from this measure can be used to monitor growth of infants, children, and adolescents and to identify potential health- or nutrition-related problems, such as obesity. Additionally, this measure can be used to monitor features of specific conditions, such as cerebral palsy, achondroplasia, Turner syndrome, and Duchenne muscular dystrophy (DMD).

Keywords

Endocrine, Infant, growth, height, weight, Developmental Delay, Learning Disability, intellectual disability, intrauterine growth restriction, IUGR, nutrition, short stature, childhood, toddler, adolescent, cerebral palsy, achondroplasia, Turner syndrome, Duchenne muscular dystrophy, DMD, obesity, stature, Gross Motor Function Classification System, GMFCS

Measure Protocols

Protocol ID	Protocol Name
221201	Growth Charts

Publications

There are no publications listed for this protocol.

Mapping for PX221201_Growth_Chart_Birth_Length

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Dietary Supplements for the Treatment of Angelman Syndrome	phv00263315	Birth Length Cms
Dietary Supplements for the Treatment of Angelman Syndrome	phv00263598	Birth length in
GENEVA Study of Preterm Delivery (African-American)	phv00160001	Child's birth length.
GENEVA Study of Preterm Delivery (African-American)	phv00160095	Child's birth length.
GENEVA Study of Preterm Delivery (African-American)	phv00160230	The length in centimeters, as recorded on the admission physical (within 72 hours of birth).
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200728	First measured length (inches)
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200729	First measured length (cm)

Mapping for PX221201_Growth_Chart_Child's_Age

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00114191	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114190	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114189	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114188	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114187	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114186	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114185	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114184	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114183	AGE OF CHILD. Q 14A
CARDIA Cohort	phv00114182	AGE OF CHILD. Q 14A
Cardiovascular Health Study (CHS) Cohort	phv00110471	AGE OF CHILD 11
Cardiovascular Health Study (CHS) Cohort	phv00110441	AGE OF CHILD 01
Cardiovascular Health Study (CHS) Cohort	phv00110468	AGE OF CHILD 10
Cardiovascular Health Study (CHS) Cohort	phv00110465	AGE OF CHILD 09
Cardiovascular Health Study (CHS) Cohort	phv00110462	AGE OF CHILD 08
Cardiovascular Health Study (CHS) Cohort	phv00110459	AGE OF CHILD 07
Cardiovascular Health Study (CHS) Cohort	phv00110456	AGE OF CHILD 06
Cardiovascular Health Study (CHS) Cohort	phv00110453	AGE OF CHILD 05
Cardiovascular Health Study (CHS) Cohort	phv00110450	AGE OF CHILD 04
Cardiovascular Health Study (CHS) Cohort	phv00110447	AGE OF CHILD 03
Cardiovascular Health Study (CHS) Cohort	phv00110444	AGE OF CHILD 02

Mapping for PX221201_Growth_Chart_Current_BMI

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Multiethnic GWAS of Prostate Cancer	phv00124446	Body mass index (BMI)
A Multiethnic GWAS of Prostate Cancer	phv00142471	Body mass index (BMI)
Asian Indian Diabetic Heart Study (AIDHS)	phv00190532	Body Mass Index of participant
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00215389	BMI = weight/((height/100)*(height/100))
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)	phv00225194	Body mass index
Cardiovascular Health Study (CHS) Cohort	phv00099468	BODY MASS INDEX
Cardiovascular Health Study (CHS) Cohort	phv00100386	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00105306	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00106840	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00110612	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00198926	Body mass index shhs2
CATHGEN: Genetic Mediators of Metabolic Cardiovascular Disease Risk	phv00197200	Body mass index at enrollment
CATHGEN: Identification of Novel Genetic and Metabolomic CV Phenotypes	phv00197180	Body mass index at enrollment
Cebu Longitudinal Health and Nutrition Survey (CLHNS)	phv00173308	Body mass index
Center for Health Discovery and Well Being (CHDWB)	phv00258902	Subject's BMI
Cholesterol and Pharmacogenetics (CAP) Study	phv00167793	Body mass index
Chronic Renal Insufficiency Cohort Study (CRIC)	phv00173257	BMI
CIP: Obesity-Diabetes Familial Risk	phv00191159	Subject's body mass index
CPMCRI Breast Health Cohort	phv00162746	Participant's BMI (body mass index)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026890	Body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027429	Body mass index (kg/m??): baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030304	Body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030686	Patient's body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030764	Patient's body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00033537	Body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034524	Body mass index (kg/m**2)
Diabetes Prevention Program Genetics (DPPG)	phv00201856	Baseline BMI
Dietary Supplements for the Treatment of Angelman Syndrome	phv00264631	BMI
Effect of LGG Probiotic on Human Whole Blood Transcriptome	phv00252691	Subject's BMI
eMERGE Network Imputed GWAS for 41 phenotypes	phv00265051	Body Mass Index (median)
Framingham Cohort	phv00056588	BMI = weight/((height/100)*(height/100))
Framingham Cohort	phv00056833	Body Mass Index (BMI = pm202/((pm207/100)*(pm207/100)))
Framingham Cohort	phv00164572	Baseline BMI in kg/m2
Framingham Cohort	phv00201408	Body Mass Index
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)	phv00163638	Body mass index of subject.
Geisinger eMERGE - MyCode Project	phv00163396	Body mass index of subject.
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082597	BMI
GeneSTAR NextGen Functional Genomics of Platelet Aggregation	phv00259622	Body mass index (calculated as weight (kg) / height (m) ^2 )
Genetic Epidemiology of COPD (COPDGene)	phv00159593	BMI
Genetic Study on Nephropathy in Type-2 Diabetes	phv00158974	Body Mass Index
GENEVA Diabetes Study (NHS/HPFS)	phv00022876	BMI in kg/m2
Genome Sequencing of Pancreatic Ductal Adenocarcinoma	phv00171502	Body Mass Index at enrollment
Genome wide association study of 24 hour urine composition in the Nurses' Health Study, Nurses' Health Study II, and the Health Professionals Follow-Up Study	phv00165553	Body mass index
Genome-wide Association Study of Adiposity in Samoans	phv00258685	Body mass index of participant
Genome-Wide Association Study of Anorexia Nervosa	phv00196927	Current BMI
Genome-Wide associations of Lung Health Study (LHS)	phv00154582	S2. Body Mass Index
Genotype-Tissue Expression (GTEx)	phv00169070	BMI
GoT2D	phv00265654	BMI
Group Health/UW Aging and Dementia eMERGE Study	phv00088219	Body_Mass_Index
GUARDIAN: IRAS (IRAS Classic)	phv00253764	Body Mass Index (Kg/M^2)
GUARDIAN: IRAS FAMILY STUDY (IRASFS)	phv00253746	Body Mass Index (Kg/M^2)
Gut Microbiome Profiles and Risk of Colorectal Cancer	phv00225132	Body mass index
GWAS for Genetic Determinants of Bone Fragility	phv00065521	Body mass index
GWAS of Breast Cancer in the African Diaspora	phv00172019	Body mass index
Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	phv00226255	BMI (kg/m2)
Hypertriglyceridemia Study in Mexicans	phv00190653	Body mass index of participant
Jackson Heart Study (JHS) Cohort	phv00165335	Baseline BMI in kg/m2
Jackson Heart Study (JHS) Cohort	phv00181209	Baseline body mass index (BMI) in kg/m2
Jackson Heart Study (JHS) Cohort	phv00265475	BMI
Metastatic Castration-resistant Prostate Cancer GWAS	phv00253374	Body Mass Index at baseline
METSIM (METabolic Syndrome In Men) Study	phv00265289	BMI
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083481	BMI
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083716	BMI
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087707	BMI
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174746	BMI AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176169	BMI AT CT
NEI Age-Related Eye Disease Study (AREDS)	phv00053923	BODY-MASS INDEX AT BASELINE (ALL PARTICIPANTS)
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190305	Baseline body mass index (BMI) in kg/m2
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122641	Body mass index
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122994	Log (BMI)
NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)	phv00160324	Baseline BMI in kg/m2
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163951	Baseline BMI in kg/m2
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190563	Baseline BMI in kg/m2
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165168	Baseline BMI in kg/m2
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178033	Baseline BMI in kg/m2
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181858	Body mass index of participant at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease)	phv00160349	ESP, Baseline BMI in kg/m2
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP	phv00161375	BASELINE BODY MASS INDEX
NHLBI TOPMed: Boston Early-Onset COPD Study in the TOPMed Program	phv00266123	Body Mass Index [BMI ]
NHLBI TOPMed: Genes-environments and Admixture in Latino Asthmatics (GALA II) Study	phv00252349	Body mass index calculated from height and weight
NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish	phv00252983	Body mass index at baseline visit
NHLBI TOPMed: Study of African Americans, Asthma, Genes and Environment (SAGE) Study	phv00252286	Body Mass Index calculated from Height and Weight
NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	phv00267373	BMI
NIA Long Life Family Study (LLFS)	phv00163255	Body Mass Index (Weight in kg/ Height in m**2)
NIDDK Genetics of Metabolic Syndrome in an Island Population	phv00222309	BMI (kg/m2)
OPPERA baseline case-control study of chronic TMJD	phv00222759	Body Mass Index (kg/m-squared; kg/m2)
OPPERA Prospective Cohort Study of First-Onset TMJD	phv00223838	Body Mass Index (kg/m-squared)
PAGE: Multiethnic Cohort (MEC)	phv00163107	Body mass index (BMI) calculated from weight & height at baseline
Patient-Specific Factors Influence Somatic Variations in VHL Tumors	phv00262207	Participant's Body Mass Index (BMI)
PGRN-RIKEN:Genetic Determinants of Cardiovascular Events while on Statins	phv00252128	Median BMI
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)	phv00200847	Body mass index
Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study	phv00173926	Body mass index of participant, calculated from measured height and weight
POLYGEN	phv00160483	Body Mass Index of participant
Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors	phv00200921	Body Mass Index (kg/m**2)
Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors	phv00200922	Body surface area (m**2)
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK	phv00020813	Body Mass Index (kg/m??) - See also GAIN - GoKinD phs000018: BMI
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN	phv00019984	Body Mass Index (kg/m??) - See also NIDDK - GoKinD phs000088: BMI
Sensitivity to the subjective effects of amphetamine	phv00221233	BMI of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070942	Baseline BMI
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071053	Baseline BMI
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071161	Baseline BMI (kg/m^2)
SNPs and Extent of Atherosclerosis (SEA) Study	phv00159046	BODY MASS INDEX
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129627	Body mass index
T2D-GENES Multi-Ethnic Exome Sequencing Study: Ashkenazi	phv00265442	BMI
T2D-GENES Multi-Ethnic Exome Sequencing Study: KARE	phv00265329	BMI
T2D-GENES Multi-Ethnic Exome Sequencing Study: Singapore	phv00265404	BMI
T2D-GENES Multi-Ethnic Exome Sequencing Study: UK South Asian	phv00265366	BMI
T2D-GENES Project 1: San Antonio Mexican American Family Studies (SAMAFS), Substudy 1: Whole exome sequencing	phv00265518	BMI
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171729	Body mass index at the most recent study visit for which we have data for this participant
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171730	Body mass index at the first study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171731	Body mass index at the second study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171732	Body mass index at the third study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171733	Body mass index at the fourth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171734	Body mass index at the fifth study visit
The Cardiopulmonary Effects of Particulate Exposure	phv00252415	Subect's body mass index
The Finland-United States Investigation of NIDDM Genetics (FUSION) Study	phv00222668	Body mass index
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00159331	BMI (kg/m2) at visit 1
The Sea Islands Genetic Network (SIGNET)	phv00163539	Body mass index derived: Wt Kg/Ht in meter squared
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066341	Body Mass Index
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066355	Body Mass Index
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00265623	BMI
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00066509	Body mass index (BMI)
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00265585	BMI
Whole Genome Association Study of Visceral Adiposity in the HABC Study	phv00071834	Body Mass Index
Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma	phv00168013	Body Mass Index
Women's Health Initiative	phv00079867	BMI

Mapping for PX221201_Growth_Chart_Current_Weight

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Genome-Wide Association Study in Breast Cancer Patients from the SUCCESS Trial	phv00174067	Weight (to calculate BMI)
A Genome-Wide Association Study of Peripheral Arterial Disease	phv00076115	Subject's weight at enrollment
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091446	WEIGHT TO THE NEAREST LB Q4
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091466	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091479	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092562	WEIGHT TO NEAREST LB Q1
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092574	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092584	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00093440	WEIGHT 4
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00097917	WEIGHT TO THE NEAREST LB Q4
CARDIA Cohort	phv00114073	WEIGHT - MON 12
CARDIA Cohort	phv00114831	SUBJECT'S WEIGHT IN POUNDS. Q 3
CARDIA Cohort	phv00115857	SUBJECT'S WEIGHT (LBS). Q 2
CARDIA Cohort	phv00117231	SUBJECT'S WEIGHT (LBS). Q 2a
CARDIA Cohort	phv00117926	WEIGHT - MON 96
CARDIA Cohort	phv00118137	WEIGHT
CARDIA Cohort	phv00118251	WEIGHT
CARDIA Cohort	phv00119094	SUBJECT'S WEIGHT (LBS). Q 2a
CARDIA Cohort	phv00119573	WEIGHT (LBS) - FORM 53
CARDIA Cohort	phv00120996	SUBJECT'S WEIGHT (LBS). Q 2a
Cardiovascular Health Study (CHS) Cohort	phv00098848	WEIGHT (lb)
Cardiovascular Health Study (CHS) Cohort	phv00099349	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00100383	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00101789	WEIGHT IN POUNDS
Cardiovascular Health Study (CHS) Cohort	phv00102454	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00104028	WEIGHT IN POUNDS AT YEAR 3 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00104759	WEIGHT IN POUNDS
Cardiovascular Health Study (CHS) Cohort	phv00105147	WEIGHT
Cardiovascular Health Study (CHS) Cohort	phv00105414	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00106776	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00107778	WEIGHT IN POUNDS AT YEAR 6 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00108569	WEIGHT IN POUNDS AT YEAR 7 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00109512	WEIGHT IN POUNDS AT YEAR 8 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00110376	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00198931	2 weight in kg (multiply by 10)
Cardiovascular Health Study (CHS) Cohort	phv00197432	Weight in kilograms
CCDG: Dental Caries and CL/P in Guatemala	phv00164777	Weight in kilograms.
Cebu Longitudinal Health and Nutrition Survey (CLHNS)	phv00173310	Weight
Chronic Renal Insufficiency Cohort Study (CRIC)	phv00173256	Weight (kg)
CIP: Obesity-Diabetes Familial Risk	phv00191157	Subject's weight
Columbia University Study of Caribbean Hispanics and Late Onset Alzheimer's disease	phv00180594	Weight of subject
CPMCRI Breast Health Cohort	phv00162745	Participant's weight
CPTAC Proteogenomic Confirmatory Study	phv00225399	Provide the weight of the participant measured in kilograms.
Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)	phv00196073	Subject's weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00025689	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026032	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026033	Current height
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026469	CBL00: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026683	CBL6: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027263	Patient's weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027317	CBL1: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027384	CBL2: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027428	Body weight (kg): baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027431	Body weight (kg): quarterly visit 01
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027434	Body weight (kg): quarterly visit 02
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027437	Body weight (kg): quarterly visit 03
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027444	Body weight (kg): quarterly visit 04
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027447	Body weight (kg): quarterly visit 05
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027450	Body weight (kg): quarterly visit 06
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027453	Body weight (kg): quarterly visit 07
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027460	Body weight (kg): quarterly visit 08
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027463	Body weight (kg): quarterly visit 09
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027466	Body weight (kg): quarterly visit 10
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027469	Body weight (kg): quarterly visit 11
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027476	Body weight (kg): quarterly visit 12
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027479	Body weight (kg): quarterly visit 13
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027482	Body weight (kg): quarterly visit 14
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027485	Body weight (kg): quarterly visit 15
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027492	Body weight (kg): quarterly visit 16
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027495	Body weight (kg): quarterly visit 17
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027498	Body weight (kg): quarterly visit 18
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027501	Body weight (kg): quarterly visit 19
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027508	Body weight (kg): quarterly visit 20
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027511	Body weight (kg): quarterly visit 21
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027514	Body weight (kg): quarterly visit 22
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027517	Body weight (kg): quarterly visit 23
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027524	Body weight (kg): quarterly visit 24
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027527	Body weight (kg): quarterly visit 25
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027530	Body weight (kg): quarterly visit 26
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027533	Body weight (kg): quarterly visit 27
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027540	Body weight (kg): quarterly visit 28
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027543	Body weight (kg): quarterly visit 29
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027546	Body weight (kg): quarterly visit 30
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027549	Body weight (kg): quarterly visit 31
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027556	Body weight (kg): quarterly visit 32
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027559	Body weight (kg): quarterly visit 33
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027562	Body weight (kg): quarterly visit 34
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027565	Body weight (kg): quarterly visit 35
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027572	Body weight (kg): quarterly visit 36
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027575	Body weight (kg): close-out
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028551	CBL7: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028927	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028929	Patient's desired weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00029760	Patient's current weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030104	Patient's weight (kg) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030409	CBL3: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030611	Weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030612	Weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030613	Weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030614	Weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030688	Patient's weight (kg) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031025	CBL9: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031092	CBL8: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031247	Current weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031598	CBL4: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031756	CBL5: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00032580	CBL10: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034114	Patient's weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034523	Weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048913	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048914	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048915	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048916	Q1d. Physical examination, weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049331	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049332	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049333	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049334	Q1d. Physical examination, weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065872	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065873	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065874	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065875	Q1d. Physical examination, weight: 4th measurement
Dental Caries GWAS	phv00090202	Weight in kilograms (kg)
Dental Caries GWAS	phv00165475	Weight in kilograms
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090694	Average weight, in kilograms
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090712	Weight - a
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090713	Weight - b
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090714	Weight - c
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090715	Weight - avg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090806	Weight a - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090807	Weight a - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090808	Weight a - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090809	Weight b - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090810	Weight b - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090811	Weight b - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090812	Weight c - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090813	Weight c - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090814	Weight c - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090815	Weight d (Average) - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090816	Weight d (Average) - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090817	Weight d (Average) - kg
eMERGE Genome-Wide Association Studies of Obesity (Metabochip)	phv00163771	Weight prior to bariatric surgery.
eMERGE Network Combined Dataset	phv00182436	Subject's weight at enrollment
FaceBase Study of Facial Shape in Tanzania: CIDR	phv00202482	Weight in kg
Familial Exome Sequencing in Rare Pediatric Phenotypes	phv00179542	Subject's weight
Family Investigation of Nephropathy and Diabetes (FIND) Study	phv00161442	Weight at enrollment
Framingham Cohort	phv00177537	Anthropometry: Weight
Framingham Cohort	phv00164574	Weight in kg. at baseline
Framingham Cohort	phv00000541	WEIGHT, EXAM 1
Framingham Cohort	phv00000552	MEDIAN WEIGHT
Framingham Cohort	phv00000632	WEIGHT, EXAM 2
Framingham Cohort	phv00000646	WEIGHT, EXAM 3
Framingham Cohort	phv00000679	WEIGHT, EXAM 4
Framingham Cohort	phv00000746	WEIGHT, EXAM 5
Framingham Cohort	phv00000829	WEIGHT, EXAM 6
Framingham Cohort	phv00000915	WEIGHT, EXAM 7
Framingham Cohort	phv00001037	WEIGHT (WHOLE POUNDS)
Framingham Cohort	phv00001189	BODY WEIGHT
Framingham Cohort	phv00001366	BODY WEIGHT
Framingham Cohort	phv00001563	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00001807	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002022	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002206	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002427	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002670	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003244	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003302	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003668	WEIGHT
Framingham Cohort	phv00004084	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00004526	WEIGHT (POUNDS, TO NEAREST POUND)
Framingham Cohort	phv00005541	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00005921	WEIGHT (TO NEAREST POUND, WITHOUT SHOES AND IN LIGHT CLOTHES)
Framingham Cohort	phv00006033	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00006328	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00006671	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00007098	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00007569	BODY WEIGHT
Framingham Cohort	phv00007676	BODY WEIGHT (KG)
Framingham Cohort	phv00007678	BODY WEIGHT (LB)
Framingham Cohort	phv00008713	WEIGHT IN POUNDS
Framingham Cohort	phv00009100	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00009552	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00010108	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00010498	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00021229	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00055259	Weight in kilograms
Framingham Cohort	phv00055291	Weight in kilograms
Framingham Cohort	phv00056838	Weight in kilograms
Framingham Cohort	phv00070552	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00072335	WEIGHT (TO NEAREST POUND)
GAW16 Framingham and Simulated Data	phv00051739	WEIGHT IN POUNDS EXAM 1
GAW16 Framingham and Simulated Data	phv00051740	WEIGHT IN POUNDS EXAM 4
GAW16 Framingham and Simulated Data	phv00051741	WEIGHT IN POUNDS EXAM 7
GAW16 Framingham and Simulated Data	phv00051742	WEIGHT IN POUNDS EXAM 11
GAW16 Framingham and Simulated Data	phv00051807	WEIGHT IN POUNDS EXAM 1
GAW16 Framingham and Simulated Data	phv00051808	WEIGHT IN POUNDS EXAM 3
GAW16 Framingham and Simulated Data	phv00051809	WEIGHT IN POUNDS EXAM 5
GAW16 Framingham and Simulated Data	phv00051810	WEIGHT IN POUNDS EXAM 7
GAW16 Framingham and Simulated Data	phv00051848	WEIGHT IN POUNDS EXAM 1
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)	phv00163636	Current weight of subject.
Geisinger eMERGE - MyCode Project	phv00163394	Current weight of subject.
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082611	Weight
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082613	Weight Units
Genes and Blood Clotting Study (GABC)	phv00124353	Participant weight at time of registration
Genetic Epidemiology of COPD (COPDGene)	phv00159591	Weight [kg]
Genetic Factors Linked with Renal Disease Progression (PediGFR) - CKiD	phv00195603	Average Weight
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073450	Weight
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073451	Weight - units
GENEVA Diabetes Study (NHS/HPFS)	phv00076250	Weight in kg at time of blood draw
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00022827	Weight to the nearest lb at visit 1
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080697	Weight to the nearest lb at visit 2
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080709	Weight to the nearest lb at visit 3
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080719	Weight to nearest lb at visit 4
Genome-Wide Association Study of Schizophrenia	phv00020423	Please enter below your current weight in pounds:
Genome-Wide Association Study of Schizophrenia	phv00034789	Please enter below your current weight in pounds:
Genomic Wide Scans for Female Osteoporosis Genes	phv00161537	Weight of study subject.
Genotype-Tissue Expression (GTEx)	phv00169069	Weight Units (Demography)
Genotype-Tissue Expression (GTEx)	phv00169068	Weight (Demography)
Group Health/UW Aging and Dementia eMERGE Study	phv00088221	Weight
GWAS for Genetic Determinants of Bone Fragility	phv00065520	Weight at primary study visit
GWAS of Breast Cancer in the African Diaspora	phv00172018	Body weight
GWAS on Cataract and HDL in the PMRP	phv00181815	How much {do you/does the participant} weigh without clothes or shoes? [If {you are/she is} currently pregnant, how much did {you/she} weigh before your pregnancy?]
GWAS on Cataract and HDL in the PMRP	phv00073576	Subject's weight at enrollment
HAPO Maternal Glycemia and Birthweight GEI Study	phv00098541	Mother's pre-pregnancy weight
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158675	Weight in pounds
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158676	Weight in kilograms
Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia	phv00161489	Subject weight
Jackson Heart Study (JHS) Cohort	phv00125861	A. Height and weight. 2: Weight to nearest kilogram [Visit 1]
Jackson Heart Study (JHS) Cohort	phv00181211	Weight in kilograms at first participant visit
Jackson Heart Study (JHS) Cohort	phv00165337	Weight in kilograms at baseline
Location and Function of Cytosine-5 Methylation in RNA	phv00226199	Subject's weight
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071649	Please enter below your current weight in pounds:
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00082685	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083472	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083707	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00084484	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00085800	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086299	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086752	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087079	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087698	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176168	WEIGHT AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176060	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176055	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175859	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174745	WEIGHT AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174637	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174632	WEIGHT (lbs)
NEIGHBOR Consortium Glaucoma GWAS	phv00129668	Weight at enrollment (lbs) 999: Missing
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes	phv00194236	Medical: Weight: lb
NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of VTE)	phv00121873	Weight at current appt date
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190307	Weight in kg. at first participant visit
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00123776	Weight (kg)
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122639	Weight in kilograms
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163953	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190565	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165170	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)	phv00179602	Weight in kg
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178036	Weight in kg at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181865	Weight of participant at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease)	phv00160352	ESP, weight in lbs. at baseline
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP	phv00165268	BASELINE WEIGHT IN KG
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200563	Prepregnancy weight (lbs)
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200564	Weight (in lbs)
PAGE: Multiethnic Cohort (MEC)	phv00163105	Weight (kg) reported at baseline
Pediatric Cardiac Genetics Consortium (PCGC)	phv00180764	Weight in kilograms
PediGFR - 4C Study Cohort	phv00221103	Weight
PediGFR - ESCAPE Trial Cohort	phv00221126	Weight
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)	phv00195999	Baseline Weight
PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events Study	phv00076277	Weight
PGRN-RIKEN NSABP Prevention Study	phv00124506	Weight
POLYGEN	phv00160482	Weight of participant
Sensitivity to the subjective effects of amphetamine	phv00221232	Weight of participant
Sequencing of Targeted Genomic Regions Associated with Smoking	phv00217971	Participant weight in pounds
Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency	phv00090683	Subject's weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070941	Baseline weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071001	Weight at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071052	Baseline Weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071109	Weight at follow-up (kg)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071160	Baseline weight (kg)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071217	Weight at follow-up (kg)
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129622	Weight
Study of Addiction: Genetics and Environment (SAGE)	phv00022913	Participant's weight in pounds
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171725	Weight at the fifth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171722	Weight at the second study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171724	Weight at the fourth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171723	Weight at the third study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171720	Weight at the most recent study visit for which we have data for this participant
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171721	Weight at the first study visit
The CARDIA-GENEVA Study	phv00129531	Subject's weight [in LBS] at Exam 5
The CARDIA-GENEVA Study	phv00129533	Subject's weight [in LBS] at Exam 6
The CARDIA-GENEVA Study	phv00129535	Subject's weight [in LBS] at Exam 7
The CARDIA-GENEVA Study	phv00129529	Subject's weight [in LBS] at Exam 4
The CARDIA-GENEVA Study	phv00129527	Subjects weight [in LBS] at Exam 3
The CARDIA-GENEVA Study	phv00129525	Subjects weight in pounds at Exam 2
The CARDIA-GENEVA Study	phv00129522	Participant's weight [in LBS] at Exam 1
The Cardiopulmonary Effects of Particulate Exposure	phv00252413	Subject's weight
The Effect of the Menstrual Cycle on the Normal Human Breast	phv00193892	Weight in pounds
The Genetic Architecture of Smoking and Smoking Cessation	phv00162809	Participant's weight in pounds
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180536	Weight (pounds)
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180469	Weight of participant (lbs)
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00179643	Weight (pounds)
The Human Virome and Febrile Illness in Children	phv00098426	Weight of the participant during collection of sample
The Sea Islands Genetic Network (SIGNET)	phv00163537	Weight at enrollment
University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders)	phv00171542	Subject's weight
Whole Genome Association Study of Bipolar Disorder	phv00035240	Please enter below your current weight in pounds. (Participants with European ancestry)
Whole Genome Association Study of Bipolar Disorder	phv00054548	Please enter below your current weight in pounds. (African American participants)
Whole-Genome Sequencing of Acute Myeloid Leukemia	phv00073673	Subject's weight in kilograms
Women's Health Initiative	phv00077673	Current weight lbs
Women's Health Initiative	phv00077799	Current weight lbs
Women's Health Initiative	phv00077909	Current weight lbs
Women's Health Initiative	phv00078111	Current weight lbs
Women's Health Initiative	phv00078235	Current weight lbs
Women's Health Initiative	phv00079558	Current weight, lbs
Women's Health Initiative	phv00079859	F80 Weight kg

Mapping for PX221201_Growth_Chart_Date_Of_Birth

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00117108	DATE OF BIRTH - 1ST CHILD
CARDIA Cohort	phv00117111	DATE OF BIRTH - 2ND CHILD
CARDIA Cohort	phv00117114	DATE OF BIRTH - 3RD CHILD
CARDIA Cohort	phv00117117	DATE OF BIRTH - 4TH CHILD
CARDIA Cohort	phv00117120	DATE OF BIRTH - 5TH CHILD
CARDIA Cohort	phv00117123	DATE OF BIRTH - 6TH CHILD
CARDIA Cohort	phv00117126	DATE OF BIRTH - 7TH CHILD
Cardiovascular Health Study (CHS) Cohort	phv00110441	AGE OF CHILD 01
Cardiovascular Health Study (CHS) Cohort	phv00110444	AGE OF CHILD 02
Cardiovascular Health Study (CHS) Cohort	phv00110447	AGE OF CHILD 03
Cardiovascular Health Study (CHS) Cohort	phv00110450	AGE OF CHILD 04
Cardiovascular Health Study (CHS) Cohort	phv00110453	AGE OF CHILD 05
Cardiovascular Health Study (CHS) Cohort	phv00110456	AGE OF CHILD 06

Mapping for PX221201_Growth_Chart_Gestational_Age

dbGAP Study	dbGAP Variable	dbGAP Variable Description
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026997	Intercurrent event - pregnancy related: gestational age
GENEVA Study of Preterm Delivery (African-American)	phv00159994	Gestational age in weeks.
GENEVA Study of Preterm Delivery (African-American)	phv00160040	Gestational age (weeks).
GENEVA Study of Preterm Delivery (African-American)	phv00160083	Gestational age weeks.
GENEVA Study of Preterm Delivery (African-American)	phv00160145	Gestational age in weeks.
GENEVA Study of Preterm Delivery (African-American)	phv00160182	Estimated gestational age.
GENEVA Study of Preterm Delivery (African-American)	phv00160223	Gestational age.
GENEVA Study of Preterm Delivery (DNBC/Iowa)	phv00121920	Gestational age at birth in days, consensus variable
GENEVA Study of Preterm Delivery (DNBC/Iowa)	phv00121921	Gestational age at birth in completed weeks, consensus variable
GWAS of Preterm Birth	phv00161691	Gestational age
HAPO Maternal Glycemia and Birthweight GEI Study	phv00098467	Baby's gestational age at delivery
HAPO Maternal Glycemia and Birthweight GEI Study	phv00098519	Baby's gestational age at delivery
HAPO Maternal Glycemia and Birthweight GEI Study	phv00112349	Baby's gestational age at delivery
HAPO Maternal Glycemia and Birthweight GEI Study	phv00121786	Baby's gestational age at delivery
HAPO Maternal Glycemia and Birthweight GEI Study	phv00163668	Baby's gestational age at delivery
The Neonatal Microbiome and NEC	phv00091262	Gestational Age in weeks at birth for subect

Mapping for PX221201_Growth_Chart_Obesity

dbGAP Study	dbGAP Variable	dbGAP Variable Description
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00159349	Obese (BMI >= 30) at visit 1

Mapping for PX221201_Growth_Chart_Overweight

dbGAP Study	dbGAP Variable	dbGAP Variable Description
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00159350	Overweight (BMI >= 25) at visit 1

Mapping for PX221201_Growth_Chart_Today's_Date

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00119634	DATE OF EXAM 2
CARDIA Cohort	phv00117591	DATE OF EXAM 4
CARDIA Cohort	phv00117590	DATE OF EXAM 3
CARDIA Cohort	phv00117589	DATE OF EXAM 2
CARDIA Cohort	phv00116541	DATE OF EXAM
CARDIA Cohort	phv00116389	DATE OF EXAM 3
CARDIA Cohort	phv00116388	DATE OF EXAM 2
CARDIA Cohort	phv00115318	DATE OF EXAM
CARDIA Cohort	phv00115117	DATE OF EXAM 2
CARDIA Cohort	phv00118300	DATE OF EXAM
CARDIA Cohort	phv00119257	DATE OF EXAM
CARDIA Cohort	phv00119628	DATE OF EXAM 5
CARDIA Cohort	phv00119635	DATE OF EXAM 3
CARDIA Cohort	phv00119636	DATE OF EXAM 4
CARDIA Cohort	phv00119727	DATE OF EXAM
CARDIA Cohort	phv00119780	DATE OF EXAM-FORM 5
CARDIA Cohort	phv00120011	DATE OF EXAM-FORM 9BCP
CARDIA Cohort	phv00120023	DATE OF EXAM-FORM 9
CARDIA Cohort	phv00120035	DATE OF EXAM-FORM 9TB
CARDIA Cohort	phv00120737	DATE OF EXAM 5
CARDIA Cohort	phv00120742	DATE OF EXAM 2
CARDIA Cohort	phv00120743	DATE OF EXAM 3
CARDIA Cohort	phv00120744	DATE OF EXAM 4
CARDIA Cohort	phv00120745	DATE OF EXAM 6
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00032148	Date of examination
Framingham Cohort	phv00010826	What is the date today? (month, day, year)
Framingham Cohort	phv00072583	What is the date today? (month, day, year)
Framingham Cohort	phv00010807	What is the date today? (month, day, year)
Framingham Cohort	phv00010845	What is the date today? (month, day, year)
Framingham Cohort	phv00010864	What is the date today? (month, day, year)
Framingham Cohort	phv00010883	What is the date today? (month, day, year)
Framingham Cohort	phv00010902	What is the date today? (month, day, year)
Framingham Cohort	phv00010921	What is the date today? (month, day, year)
Framingham Cohort	phv00010940	What is the date today? (month, day, year)
Framingham Cohort	phv00010959	What is the date today? (month, day, year)
Framingham Cohort	phv00010978	What is the date today? (month, day, year)
Framingham Cohort	phv00010997	What is the date today? (month, day, year)
Framingham Cohort	phv00011018	What is the date today? (month, day, year)
Framingham Cohort	phv00011037	What is the date today? (month, day, year)
Framingham Cohort	phv00011056	What is the date today? (month, day, year)
Framingham Cohort	phv00072602	What is the date today? (month, day, year)
IMSGC Genome Wide Association Study of Multiple Sclerosis	phv00065554	Date of exam
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180273	What is today's date?
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180314	Date of exam
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180446	Today's date